Concepedia

Assia L. Angelova

AL

10

Publications

661

Citations

10

H-Index

2009

Active since

Affiliations

Heidelberg University(Current)

German Cancer Research Center

University Hospital Heidelberg

Institut de Recherche contre les Cancers de l’Appareil Digestif

Inserm

Assia L. Angelova is an author at Heidelberg University specializing in virology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2009–2021

10

Publications

10

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Karsten Geletneky, Jacek Hajda, Assia L. Angelova et al. · Molecular Therapy · 2017 · 249 citations · Full text

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

Assia L. Angelova, Marc Aprahamian, Svitlana P. Grekova et al. · Clinical Cancer Research · 2009 · 92 citations

Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer

Assia L. Angelova, Svitlana P. Grekova, Anette Heller et al. · Journal of Virology · 2014 · 73 citations · Full text

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

Assia L. Angelova, Marc Aprahamian, Ginette Balboni et al. · Molecular Therapy · 2009 · 51 citations · Full text

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Jacek Hajda, Monika Lehmann, Ottheinz Krebs et al. · BMC Cancer · 2017 · 44 citations · Full text

Rows per page

1–5 of 10